市場調查報告書 - 171765

肺癌治療藥物產品線最新情況

Lung Cancer Drug Pipeline Update 2014

出版商 BioSeeker Group AB
出版日期 2014年03月25日 內容資訊 英文
價格
肺癌治療藥物產品線最新情況 Lung Cancer Drug Pipeline Update 2014
出版日期: 2014年03月25日 內容資訊: 英文
簡介

本報告為,匯整肺癌治療藥物清單及其開發階段、開發計畫、221種以上標靶相關資訊之系統整理,以下列摘要形式闡述。

※本產品為CD-ROM。內容提供數據庫之應用。使用前必須先安裝至電腦中。

臨床實驗擔任醫師

  • 335位

藥劑名稱(別名)

  • 商標名、非專利藥物名、代號

開發階段

  • 442種藥劑中508個開發計畫
    • 已上市
    • 已註冊
    • 註冊前
    • 第III相計畫
    • 第II相計畫
    • 第I相計畫
    • 臨床前
    • 無數據
    • 中斷
    • 中止

適應

標靶

  • 242種標靶藥劑以61種分類
  • 標靶以25種本地化分類

標靶發現簡介

標靶訊息路徑

機轉

化合物

藥劑簡介

  • 藥劑名
  • 臨床實驗擔任醫師及合作夥伴
  • 標靶及標靶分子功能
  • 標靶部分
  • 標靶發現簡介
  • 標靶路徑
  • 機轉
  • 開發計畫
  • 藥劑解說
  • 化合物數據
  • 專利數據
  • 商業及市場
  • 第3相數據
  • 第2相數據
  • 第1相數據
  • 臨床實驗前數據
  • 授權資訊

應用特性

  • 13種參數
  • 網路資源應用
  • 資訊提供及共享

系統要件

  • Operating system: Windows (2000/XP/Vista/7/8) for Mac Users the service is only available online
  • Browser Application (Internet Explorer, Firefox, Chrome, Safari)
  • Internet access (to access related internet resources)

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) comprises over 95% of all lung cancers. High unmet needs still persist for this tumor type and despite two decades of extensive R&D and chemotherapy use, the median overall survival of NSCLC patient's remains below 12 months. Mesothelioma is rarer, although incidence is expected to increase in the coming years in Europe and Japan given the heavy use of asbestos in the 1970s and long latency period of the disease.

There are today 364 companies plus partners developing 495 lung cancer drugs in 581 developmental projects in cancer. In addition, there are 11 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 222 drugs. Lung Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 325 different targets. All included targets have been cross-referenced for the presence of mutations associated with human cancer. To date 313 out of the 316 studied drug targets so far have been recorded with somatic mutations. The software application lets you narrow in on these mutations and links out to the mutational analysis for each of the drug targets for detailed information. All drugs targets are further categorized on in the software application by 68 classifications of molecular function and with pathway referrals to BioCarta, KEGG, NCI-Nature and NetPath.

How May Drug Pipeline Update Be of Use?

  • Show investors/board/management that you are right on top of drug development progress in your therapeutic area.
  • Find competitors, collaborations partners, M&A candidates etc.
  • Jump start competitive drug intelligence operations
  • Excellent starting point for world wide benchmarking
  • Compare portfolio and therapy focus with your peers
  • Speed up pro-active in-/out licensing strategy work
  • Fast and easy way of tracking drugs using search engines; just one click from inside the application and you may search the World Wide Web and PubMed for any drug. Drug Pipeline Update is delivered to you as a downloadable application, which requires no installation on your computer. Please read more about application features and system requirements below.

Drug Pipeline Update at a Glance

Investigators

  • Includes more than 364 principal companies plus their collaborators. There is direct access from inside the application to web pages of all principal companies.
  • Note: You are able to sort and find drugs according to companies and partners from drop-down menus in the application. You may also sort and find drugs according to country of companies.

Drug name & Synonyms

  • Lists commercial, generic and code names for drugs.

Developmental stage

  • This Drug Pipeline Update contains 495 lung cancer drugs in development, which have a total of 581 developmental projects in cancer. In addition there are suspended and ceased drugs.
  • Pipeline Breakdown According to Number of Drugs
  • Marketed# 39
  • Pre-registration# 5
  • Phase III# 42
  • Phase II# 219
  • Phase I# 135
  • Preclinical# 94
  • No Data# 2
  • Suspended# 11
  • Ceased# 222
  • Note: You are able to sort and find drugs according to developmental stage from drop-down menu in the application.

Indications

  • Included lung cancer drugs are also in development for 258 other indications, where of 158 are different cancer indications.
  • Note: You are able to find and sort drugs according to type of indication from drop-down menu in the application.

Targets

  • Mutations
  • All targets are cross-referenced with the Catalogue of Somatic Mutations in Cancer (COSMIC). It is designed to store and display somatic mutation information and related details and contains information relating to human cancers. To date 313 out of the 316 studied drug targets so far have been recorded with somatic mutations and the software application lets you narrow in on these mutations and links out to the mutational analysis for each of the drug targets for detailed information.
  • Biological Structures
  • The identity of available biological structures on 223 drug targets was retrieved from the RCSB Protein Databank for you to easily review the 3874 structures available today among drug targets.
  • Identified drugs are linked to more than 325 different targets, divided into 68 classifications of molecular function:
  • Aminopeptidase activity
  • Auxiliary transport protein activity
  • Carboxy-lyase activity
  • Catalytic activity
  • Cell adhesion molecule activity
  • Chaperone activity
  • Chemokine activity
  • Cofactor binding
  • Complement activity
  • Cysteine-type peptidase activity
  • Cytokine activity
  • Deacetylase activity
  • Deaminase activity
  • DNA binding
  • DNA repair protein
  • DNA topoisomerase activity
  • DNA-directed DNA polymerase activity
  • DNA-methyltransferase activity
  • Extracellular ligand-gated ion channel activity
  • Extracellular matrix structural constituent
  • Fucosyltransferase activity
  • G-protein coupled receptor activity
  • Glutathione transferase activity
  • Growth factor activity
  • GTPase activity
  • Heat shock protein activity
  • Hormone activity
  • Hydrolase activity
  • Intracellular ligand-gated ion channel activity
  • Ion channel activity
  • Isomerase activity
  • Kinase activity
  • Kinase regulator activity
  • Ligand-dependent nuclear receptor activity
  • Ligase activity
  • Lipase activity
  • Lipid kinase activity
  • Lipid phosphatase activity
  • Metallopeptidase activity
  • MHC class I receptor activity
  • Molecular function unknown
  • Motor activity
  • Oxidoreductase activity
  • Peptidase activity
  • Peroxidase activity
  • Phosphoric diester hydrolase activity
  • Protein binding
  • Protein serine/threonine kinase activity
  • Protein threonine/tyrosine kinase activity
  • Protein tyrosine/serine/threonine phosphatase activity
  • Protein-tyrosine kinase activity
  • Receptor activity
  • Receptor binding
  • Receptor signaling complex scaffold activity
  • Receptor signaling protein serine/threonine kinase activity
  • RNA binding
  • RNA-directed DNA polymerase activity
  • Serine-type peptidase activity
  • Structural constituent of cytoskeleton
  • Structural molecule activity
  • Transcription factor activity
  • Transcription regulator activity
  • Transferase activity
  • Translation regulator activity
  • Transmembrane receptor activity
  • Transmembrane receptor protein tyrosine kinase activity
  • Transporter activity
  • Ubiquitin-specific protease activity
  • Sub-Cellular Localization
  • Identified targets are categorized into 27 different primary and alternate sub-cellular localizations:
  • Cell surface
  • Centrosome
  • Chromosome
  • Clathrin-coated vesicle
  • Cytoplasm
  • Cytoplasmic vesicle
  • Cytoskeleton
  • Cytosol
  • Endoplasmic reticulum
  • Endosome
  • Extracellular
  • Golgi apparatus
  • Integral to membrane
  • Kinetochore
  • Lysosome
  • Microtubule
  • Mitochondrial membrane
  • Mitochondrion
  • Nuclear membrane
  • Nucleolus
  • Nucleus
  • Perinuclear region
  • Perinuclear vesicle
  • Plasma membrane
  • Sarcoplasmic reticulum
  • Secreted
  • Secretory granule
  • Note: You are able to find and sort drugs according to target gene name, protein name, molecular function of target, target localization, presence of mutations and availability of biological structures of target from drop-down menus in the application.

Target Expression Profile

  • Direct links are provided from inside the application to 449 protein expression profiles of 281 drug targets in various human tissues and cancer types, cell lines and primary cells, including up to:
  • 48 different normal tissue types
  • 20 different types of cancer
  • 47 cell lines
  • 12 samples of primary blood cells

Pathway Referals

  • Identified targets have been cross referenced against their involvement in different cellular pathways, according to BioCarta, KEGG, NCI-Nature and NetPath.
  • BioCarta# 254 Pathways
  • KEGG# 182 Pathways
  • NCI-Nature# 251 Pathways
  • NetPath# 32 Pathways
  • Note: You are able to find and sort drugs according to targeted pathways from drop-down menus in the application.

Mechanism

  • In total there are different drug mechanism of action represented in this Drug Pipeline Update.
  • Note: You are able to find and sort drugs according to mechanism of action from drop-down menu in the application.

Compound

  • Identified drug compounds are described by:
  • Compound type, Chemical name, CAS Number and molecular weight
  • Note: You are able to sort and find drugs according to compound type from drop-down menu in the application.

Drug Profile

  • Progress analysis and review of drug development. A typical drug profile reports on, depending on stage of development and available information:
  • Drug Name & Synonyms
  • Presentation of drug name and synonyms

Principal Company & Partners

  • Presentation of principal company and partners

Target and Molecular Function of Target

  • Described target(s) is/are presented with:
  • Official Gene Symbol - Chromosome Location - Gene & Protein Name - Molecular Function

Target Localization

  • Described target(s) is/are presented with primary and alternate localizations.
  • Target Expression Profiles
  • Links to protein expression profile(s) of target(s) in various human tissues, cell lines and primary cells, including up to:
  • 48 different normal tissue types
  • 20 different types of cancer
  • 47 cell lines
  • 12 samples of primary blood cells

Mutation

  • All targets are cross-referenced with the Catalogue of Somatic Mutations in Cancer (COSMIC). It is designed to store and display somatic mutation information and related details and contains information relating to human cancers.
  • Biological Structures
  • The identity of available biological structures on drug targets was retrieved from the RCSB Protein Databank for you to easily review what available structures of drug targets exist.

Targeted Pathways

  • Described target(s) is/are matched for the involvement in cellular pathways according to BioCarta, KEGG, NCI-Nature and NetPath.

Mechanism

  • Drug mechanism of action

Developmental Projects

  • Summary field of developmental projects for the drug, including indication, developmental stage and status.
  • Example:
  • Cancer, myeloma - Phase II Clinical Trial - Active
  • Cancer, prostate - Phase III Clinical Trial - Ceased

Drug Description

  • Short introduction to drug

Compound Data

  • Compound type, Chemical name, CAS Number and molecular weight

Patent Data

  • Available patent information related to the drug is presented here.

Fillings and Approvals

  • Approvals and submissions
  • Analyst comments
  • Deals & Licensing
  • Collaborations and deals
  • Availability for licensing

Phase IV Data

  • Available Phase IV development data, developmental history and scientific data.

Phase III Data

  • Available Phase III development data, developmental history and scientific data.

Phase II Data

  • Available Phase II development data, developmental history and scientific data.

Phase I Data

  • Available Phase I development data, developmental history and scientific data.

Phase 0 Data

  • Available Phase 0 development data, developmental history and scientific data.

Preclinical Data

  • Available preclinical development data, developmental history and scientific data.

Discovery Data

  • Available discovery development data, developmental history and scientific data.

Application Features

  • Search, Find and Filter Panel with Initial Result Presentation
  • With this panel you can define your selectivity in each drug search with up to 24 different drug specific parameters. Each parameter has multi-select options to them and can be used as either an inclusion parameter or exclusion parameter.
  • The initial result table is a dynamic sortable table which gives you a fast overview of found results and can be narrowed down further by your own additional keywords.
  • Direct linkage from inside the application to related internet resources
  • Drug data is linked to search engines like Google and PubMed
  • Drug target data is linked directly to BioCarta, Human Protein Atlas, KEGG, NCI-Nature, NetPath etc.
  • Direct links to company web pages of companies

Dynamic Report Generator

  • Our dynamic report generator lets you with ease and speed generate html reports directly in your web browser (Internet Explorer and FireFox), whether it is a single drug profile or an entire search you want have a report of.

System Requirements

  • Operating system: Windows (2000/XP/Vista/7/8) for Mac Users the service is only available online
  • Browser Application (Internet Explorer, Firefox, Chrome, Safari)
  • Internet access (to access related internet resources)

肺癌治療藥物產品線最新情況是由出版商BioSeeker Group AB在2014年03月25日所出版的。這份市場調查報告書價格從美金2248起跳。

Back to Top
;